Prostate Cancer and Prostatic Diseases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide
Prostate Cancer and Prostatic Diseases, Published online: 08 October 2022; doi:10.1038/s41391-022-00592-9Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 8, 2022 Category: Urology & Nephrology Authors: YaoYao Pollock Matthew R. Smith Fred Saad Simon Chowdhury St éphane Oudard Boris Hadaschik David Olmos Ji Youl Lee Hiroji Uemura Amitabha Bhaumik Anil Londhe Brendan Rooney Sabine D. Brookman-May Peter De Porre Suneel D. Mundle Eric J. Small Source Type: research

Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions
Prostate Cancer and Prostatic Diseases, Published online: 08 October 2022; doi:10.1038/s41391-022-00606-6Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictions (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 8, 2022 Category: Urology & Nephrology Authors: Alberto Martini Alae Touzani Elio Mazzone Mathieu Roumigui é Giancarlo Marra Massimo Valerio Jean Baptiste Beauval Riccardo Campi Andrea Minervini Roderick C. N. van den Berg Timo F. W. Soeterik Junlong Zhuang Hongqian Guo Paolo Gontero Francesco Montors Source Type: research

Second generation anti-androgens and androgen deprivation therapy with radiation therapy in the definitive management of high-risk prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 06 October 2022; doi:10.1038/s41391-022-00598-3Second generation anti-androgens and androgen deprivation therapy with radiation therapy in the definitive management of high-risk prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 6, 2022 Category: Urology & Nephrology Authors: Edina C. Wang W. Robert Lee Andrew J. Armstrong Source Type: research

Screening of visceral metastasis in castration-resistant prostate cancer: a cornerstone in personalized patient’s care
Prostate Cancer and Prostatic Diseases, Published online: 06 October 2022; doi:10.1038/s41391-022-00604-8Screening of visceral metastasis in castration-resistant prostate cancer: a cornerstone in personalized patient’s care (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 6, 2022 Category: Urology & Nephrology Authors: Elisabeth Grobet-Jeandin Massimo Valerio Source Type: research

Allopurinol and prostate cancer survival in a Finnish population-based cohort
Prostate Cancer and Prostatic Diseases, Published online: 21 September 2022; doi:10.1038/s41391-022-00597-4Allopurinol and prostate cancer survival in a Finnish population-based cohort (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 21, 2022 Category: Urology & Nephrology Authors: Ville Kukko Antti Kaipia Kirsi Talala Kimmo Taari Teuvo L. J. Tammela Anssi Auvinen Teemu J. Murtola Source Type: research

To all men with urinary symptoms – seek help early!
Prostate Cancer and Prostatic Diseases, Published online: 16 September 2022; doi:10.1038/s41391-022-00594-7To all men with urinary symptoms – seek help early! (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 16, 2022 Category: Urology & Nephrology Authors: Jeremy Yuen-Chun Teoh Source Type: research

Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases
Prostate Cancer and Prostatic Diseases, Published online: 14 September 2022; doi:10.1038/s41391-022-00588-5Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 14, 2022 Category: Urology & Nephrology Authors: Martin W. Schoen Kenneth R. Carson Seth A. Eisen Charles L. Bennett Suhong Luo Melissa A. Reimers Eric M. Knoche Alison L. Whitmer Yan Yan Bettina F. Drake Kristen M. Sanfilippo Source Type: research

Characterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormones
Prostate Cancer and Prostatic Diseases, Published online: 13 September 2022; doi:10.1038/s41391-022-00590-xCharacterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormones (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 13, 2022 Category: Urology & Nephrology Authors: Minas J. Sakellakis Andrew W. Hahn Sumankalai Ramachandran Miao Zhang Anh Hoang Jian H. Song Jingjing Liu Feng Wang Hirak S. Basu Peter Sheperd Xuemei Wang Daniel E. Frigo Sue-Hwa Lin Theocharis Panaretakis Jianhua Zhang Nora Navone Patricia Troncoso Chri Source Type: research

Association of dynamic change in patient-reported pain with survival in metastatic castrate sensitive prostate cancer—exploratory analysis of LATITUDE study
Prostate Cancer and Prostatic Diseases, Published online: 13 September 2022; doi:10.1038/s41391-022-00529-2Association of dynamic change in patient-reported pain with survival in metastatic castrate sensitive prostate cancer—exploratory analysis of LATITUDE study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 13, 2022 Category: Urology & Nephrology Authors: Soumyajit Roy Scott C. Morgan Christopher J. D. Wallis Yilun Sun Daniel E. Spratt Julia Malone Scott Grimes Dibya Mukherjee Amar U. Kishan Fred Saad Shawn Malone Source Type: research

Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy
Prostate Cancer and Prostatic Diseases, Published online: 12 September 2022; doi:10.1038/s41391-022-00591-wProspective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 12, 2022 Category: Urology & Nephrology Authors: Stefan E. Eng Benjamin Basasie Alfonso Lam O. John Semmes Dean A. Troyer Geoffrey D. Clarke Abhijit G. Sunnapwar Robin J. Leach Teresa L. Johnson-Pais Lori J. Sokoll Daniel W. Chan Jeffrey J. Tosoian Javed Siddiqui Arul M. Chinnaiyan Ian M. Thompson Jr. P Source Type: research

Prebiopsy 68Ga-PSMA PET imaging: can we improve the current diagnostic pathway for prostate cancer?
Prostate Cancer and Prostatic Diseases, Published online: 09 September 2022; doi:10.1038/s41391-022-00593-8Prebiopsy 68Ga-PSMA PET imaging: can we improve the current diagnostic pathway for prostate cancer? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 9, 2022 Category: Urology & Nephrology Authors: Simone Albisinni Julien Sarkis Romain Diamand Cosimo De Nunzio Source Type: research

The evolving standards of active surveillance monitoring
Prostate Cancer and Prostatic Diseases, Published online: 09 September 2022; doi:10.1038/s41391-022-00595-6The evolving standards of active surveillance monitoring (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 9, 2022 Category: Urology & Nephrology Authors: Peter C. Albertsen Source Type: research

Survivorship in prostate cancer following robotic assisted radical prostatectomy–the time to act is now!
Prostate Cancer and Prostatic Diseases, Published online: 05 September 2022; doi:10.1038/s41391-022-00589-4Survivorship in prostate cancer following robotic assisted radical prostatectomy–the time to act is now! (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 5, 2022 Category: Urology & Nephrology Authors: Findlay MacAskill Majed Shabbir Arun Sahai Source Type: research

Clinical management and outcomes of HIV-positive patients newly diagnosed with prostate cancer: a single institution experience
Prostate Cancer and Prostatic Diseases, Published online: 03 September 2022; doi:10.1038/s41391-022-00586-7Clinical management and outcomes of HIV-positive patients newly diagnosed with prostate cancer: a single institution experience (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 3, 2022 Category: Urology & Nephrology Authors: Mark C. Markowski Filip Pirsl Jeanne C. Keruly Geetanjali Chander Richard D. Moore Bryan Lau Corinne E. Joshu Source Type: research

The role of ferroptosis in prostate cancer: a novel therapeutic strategy
Prostate Cancer and Prostatic Diseases, Published online: 02 September 2022; doi:10.1038/s41391-022-00583-wThe role of ferroptosis in prostate cancer: a novel therapeutic strategy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 2, 2022 Category: Urology & Nephrology Authors: Yue Wang Yifan Ma Kui Jiang Source Type: research